About CTI Clinical Trial
CTI Clinical Trial is a company based in Cincinnati (United States) founded in 1999 by Timothy Schroeder. It operates as a B2B. CTI Clinical Trial has completed 4 acquisitions, including CTI Clinical Trial and Consulting, ClinArt Mena and Dynakin. CTI Clinical Trial offers products and services including Clinical Services, Regulatory Development, and Lab Services. CTI Clinical Trial operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Cincinnati, United States
- Founders Timothy Schroeder
-
Sectors
Business ServicesHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
CTI Clinical Trial and Consulting
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CTI Clinical Trial
CTI Clinical Trial offers a comprehensive portfolio of products and services, including Clinical Services, Regulatory Development, and Lab Services.
Manages clinical trials and monitoring for healthcare studies
Provides strategic advice on regulatory affairs and compliance
Offers bioanalytical and safety testing for research purposes
People of CTI Clinical Trial
Unlock access to complete
Funding Insights of CTI Clinical Trial
Detailed funding history for CTI Clinical Trial
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CTI Clinical Trial
CTI Clinical Trial has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include CTI Clinical Trial and Consulting, ClinArt Mena and Dynakin.
Investment portfolio details for CTI Clinical Trial
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Translational drug development services are provided from pre-clinical to marketing.
|
Locked | Locked | 2004 | Locked | |
|
Customized services for global phase 1-4 clinical trials are delivered.
|
Locked | Locked | 2001 | Locked | |
|
Full-service clinical trial management and consulting services are provided.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for CTI Clinical Trial
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CTI Clinical Trial
Detailed financials for CTI Clinical Trial
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cti Clinical Trial Comparisons
Peer comparison for CTI Clinical Trial
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CTI Clinical Trial
CTI Clinical Trial operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of CTI Clinical Trial
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cti Clinical Trial
Complete news archive for CTI Clinical Trial
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CTI Clinical Trial
CTI Clinical Trial was founded in 1999.
CTI Clinical Trial is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.
Timothy Schroeder is the current CEO of CTI Clinical Trial. They have also founded this company.
CTI Clinical Trial Consulting specializes in clinical research and consulting, focusing on therapeutic areas like rare diseases and immunology. They deliver services including regulatory development, clinical monitoring, lab testing, and real-world evidence generation. Operating from Covington, Kentucky, the company supports pharmaceutical and biotech firms through project management and safety oversight, ensuring compliance and efficient trial execution.
CTI Clinical Trial's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
CTI Clinical Trial offers Clinical Services, Regulatory Development, and Lab Services.
CTI Clinical Trial has made 4 acquisitions, including CTI Clinical Trial and Consulting, ClinArt Mena, and Dynakin.